Briggs Morrison's Net Worth

$18.8 Million

Estimate Recalculated Sep 29, 2025 08:01PM EST

Who is Briggs Morrison

Briggs Morrison has an estimated net worth of $18.8 Million. This is based on reported shares across multiple companies, which include Repare Therapeutics Inc., Syndax Pharmaceuticals Inc, ARVINAS, INC., Codiak BioSciences, Inc., NextCure, Inc., Werewolf Therapeutics, Inc., Oncorus, Inc., and Carisma Therapeutics Inc..

SEC CIK

Briggs Morrison's CIK is 0001654430

Past Insider Trading and Trends

2022 was Briggs Morrison's most active year for acquiring shares with 17 total transactions. Briggs Morrison's most active month to acquire stocks was the month of May. 2022 was Briggs Morrison's most active year for disposing of shares, totalling 31 transactions. Briggs Morrison's most active month to dispose stocks was the month of August. 2022 saw Briggs Morrison paying a total of $8,930,918.70 for 926,214 shares, this is the most they've acquired in one year. In 2022 Briggs Morrison cashed out on 1,357,215 shares for a total of $16,395,184.89, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Repare Therapeutics Inc.

Investor
Updated Jun 20, 2024
Form 4
27.20K
Jun 20, 2024
27.20K
Grant
Jun 17
Form 4
27.20K
Jun 12, 2023
27.20K
Grant
Jun 08
Form 4
49.00K
May 16, 2022
49.00K
Grant
May 13
Form 4
21.00K
May 14, 2021
21.00K
Grant
May 13
Form 4
4.80K
$20.00
$96.00K
Jun 25, 2020
4.80K
Purchase
Jun 23
Form 3
Jun 18, 2020
Showing 6 results

Syndax Pharmaceuticals Inc

President, Head R&D
Updated Feb 09, 2024
Form 4
95.31%
17.00K
Feb 09, 2024
34.84K
Grant
Feb 07
Form 4
-74.77%
-52.85K
$13.52
-$501.86K
Aug 10, 2023
17.84K
Sale
Aug 09
Form 4
-74.77%
-52.85K
$14.59
-$614.53K
Jul 11, 2023
17.84K
Sale
Jul 10
Form 4
-74.77%
-52.85K
$14.42
-$714.63K
Jun 09, 2023
17.84K
Sale
Jun 09
Form 4
-74.77%
-52.85K
$13.90
-$794.26K
May 10, 2023
17.84K
Sale
May 09
Form 4
-74.77%
-52.85K
$12.96
-$695.02K
Apr 12, 2023
17.84K
Sale
Apr 10
Form 4
-74.77%
-52.85K
$14.46
-$853.47K
Mar 14, 2023
17.84K
Sale
ScheduledMar 13
Form 4
-74.77%
-52.85K
$16.61
-$1.08M
Feb 08, 2023
17.84K
Sale
ScheduledFeb 06
Form 4
32.00K
$28.55
$913.60K
Feb 03, 2023
32.00K
Grant
Feb 02
Form 4
-90.70%
-173.99K
$17.01
-$2.12M
Sep 21, 2022
17.84K
Sale
ScheduledSep 19 - Sep 20
Form 4
-94.00%
-279.42K
$15.77
-$4.40M
Sep 16, 2022
17.84K
Sale
ScheduledSep 14 - Sep 16
Form 4
-77.74%
-62.29K
$13.10
-$734.93K
Jul 05, 2022
17.84K
Sale
ScheduledJul 01
Form 4/A
$7.20
$530.45K
Apr 13, 2022
109.35K
Options
Apr 01 - Apr 04
Form 4
-85.38%
-104.17K
$14.19
-$1.02M
Apr 05, 2022
17.84K
Sale
ScheduledApr 01 - Apr 04
Form 4
160.00K
$15.79
$2.53M
Feb 03, 2022
160.00K
Grant
Feb 02
Form 4
-42.11%
-35.16K
$15.45
-$319.92K
Dec 20, 2021
48.34K
Sale
ScheduledDec 17
Form 4
-59.26%
-70.31K
$13.64
-$904.77K
Sep 21, 2021
48.34K
Sale
ScheduledSep 17 - Sep 20
Form 4
-42.11%
-35.16K
$13.88
-$469.28K
Feb 10, 2021
48.34K
Sale
ScheduledFeb 08
Form 4
422.57%
196.77K
$12.00
$21.25K
Feb 05, 2021
243.34K
Acquisition
Jan 31 - Feb 03
Form 4
-63.33%
-80.40K
$13.62
-$1.03M
Nov 12, 2020
46.57K
Sale
Nov 09 - Nov 10
Form 4
194.00K
Feb 14, 2020
194.00K
Grant
Feb 12
Form 4
39.81%
12.50K
$8.00
$100.00K
Feb 05, 2020
43.90K
Purchase
Feb 04
Form 4
53.92%
11.00K
$5.40
$59.40K
Oct 11, 2019
31.40K
Purchase
Oct 10
Form 4
20.40K
$7.46
$152.24K
May 13, 2019
20.40K
Purchase
May 09 - May 13
Form 4
354.00K
Feb 08, 2019
354.00K
Grant
Feb 06
Form 4
200.00K
Mar 05, 2018
200.00K
Grant
Mar 01
Form 4
160.00K
Feb 08, 2017
160.00K
Grant
Feb 06
Form 3
Mar 02, 2016
Showing 28 results

ARVINAS, INC.

Investor
Updated May 31, 2024
Form 4
62.12%
14.97K
May 31, 2024
39.07K
Grant
May 29
Form 4
84.64%
16.91K
Jun 20, 2023
36.88K
Grant
Jun 15
Form 4
10.19K
Jun 21, 2022
10.19K
Grant
Jun 16
Form 4
-50.59%
-20.96K
$41.22
-$1.13M
Apr 18, 2022
20.47K
Sale
ScheduledApr 14
Form 4
-33.60%
-20.96K
$40.78
-$1.12M
Jan 19, 2022
41.43K
Sale
ScheduledJan 14
Form 4
7.51K
Jun 10, 2021
7.51K
Grant
Jun 08
Form 4
12.00K
Jun 04, 2020
12.00K
Grant
Jun 03
Form 4
9.25%
2.50K
$38.18
$95.45K
Mar 25, 2020
29.52K
Purchase
Mar 24
Form 4
12.92K
May 28, 2019
12.92K
Grant
May 23
Form 4
39.83K
Sep 28, 2018
39.83K
Grant
Sep 26
Form 3
Sep 26, 2018
27.02K
Showing 11 results

Codiak BioSciences, Inc.

Investor
Updated Feb 17, 2021
Form 4
4.76K
$21.00
$99.98K
Feb 17, 2021
4.76K
Purchase
Feb 17
Form 4
10.00K
Oct 15, 2020
10.00K
Grant
Oct 13
Form 3
Oct 13, 2020
Showing 3 results

NextCure, Inc.

Investor
Updated Jun 15, 2020
Form 4
14.25K
Jun 15, 2020
14.25K
Grant
Jun 11
Form 4
22.00K
Jun 17, 2019
22.00K
Grant
Jun 13
Form 3
May 08, 2019
Showing 3 results

Werewolf Therapeutics, Inc.

Investor
Updated May 24, 2024
Form 4
17.50K
May 24, 2024
17.50K
Grant
May 24
Form 4
13.20K
Jun 23, 2023
13.20K
Grant
Jun 21
Form 4
11.60K
Jun 03, 2022
11.60K
Grant
Jun 01
Form 4
23.20K
May 04, 2021
23.20K
Grant
Apr 30
Form 3
Apr 29, 2021
15.52K
Showing 5 results

Oncorus, Inc.

Investor
Updated Oct 01, 2020
Form 3
Oct 01, 2020
Showing 1 results

Carisma Therapeutics Inc.

Investor
Updated Jun 27, 2024
Form 4
19.35K
Jun 27, 2024
19.35K
Grant
Jun 26
Form 4
38.70K
Jun 08, 2023
38.70K
Grant
Jun 06
Form 4
109.67K
Mar 09, 2023
109.67K
Grant
Mar 07
Form 3
Mar 09, 2023
Showing 4 results

CRISPR Therapeutics AG

Investor
Updated Jun 10, 2025
Form 3/A
Jun 10, 2025
5.21K
Showing 1 results